Company intelligence / Profile preview

Oncodia

Uppsala, Sweden

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Oncodia has developed and commercialized CE-IVD certified software and fully automated extraction devices to support accurate and robust mutation analysis in clinical oncology; products facilitate precision cancer therapy selection

Therapeutic areas: Oncology
Modalities: Software (for analysis of sequencing data)Device (for fully automated DNA/RNA extraction)
Industry: Molecular Diagnostics

Partnerships

EU Horizon 2020EIT Health

Beyond the preview

Go deeper on Oncodia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oncodia.

Explore the full profile